Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa

Molecular Pharmaceutics

Volumn 6, Issue 4, 2009, Pages 1083-1091

  Tirosh, Boaz ^a   Khatib, Nadine ^a   Barenholz, Yechezkel ^b   Nissan, Aviram ^c   Rubinstein, Abraham ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Induced colitis; Mucosa; Negatively charged liposomes; pH; Specific attachment; Transferrin

Indexed keywords

LIPOSOME; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG TARGETING; ELECTRICITY; HISTOPATHOLOGY; MALE; MUCOADHESION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; TANDEM MASS SPECTROMETRY; TISSUE SECTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; COLITIS; COLON; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; LIPOSOMES; MALE; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY; TRANSFERRIN;

EID: 68249087581     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp9000926     Document Type: Article

References (38)

1. Isaacs, K. L.; Lewis, J. D.; Sandborn, W. J.; Sands, B. E.; Targan, S. R. State of the art: IBD therapy and clinical trials in IBD. Inflammatory Bowel Dis. 2005, S3-12.
2. Targan, S. R.; Shanahan, F.; Karp, L. C. Inflammatory Bowel Disease: From Bench to Bedside, 2nd ed.; Springer: New York, 2005; p 903.
3. Kurtovic, J.; Segal, I. Recent advances in biological therapy for inflammatory bowel disease. Trop. Gastroenterol. 2004, 25, 9-14.
4. Scholmerich, J.; Huber, G. Biological therapy in IBD. Anti-tumor necrosis factor-alpha and others. Dig. Dis. 2003, 21, 180-191. (Pubitemid 37323495)
5. Targan, S. R. Current limitations of IBD treatment: where do we go from here? Ann. N.Y. Acad. Sci. 2006, 1072, 1-8. (Pubitemid 44448438)
6. Campieri, M. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal. Gut 2002, 50, III43-III46. (Pubitemid 34413562)
7. Hanauer, S. B. Review article: evolving concepts in treatment and disease modification in ulcerative colitis. Aliment. Pharmacol. Ther. 2008, 27, 15-21.
8. Kesisoglou, F.; Zimmermann, E. M. Novel drug delivery strategies for the treatment of inflammatory bowel disease. Expert Opin. Drug Delivery 2005, 2, 451-463. (Pubitemid 41683221)
9. Rubinstein, A. Colonic drug delivery. Drug Discovery Today: Technol. 2005, 2, 33-37.
10. Steidler, L.; Hans, W.; Schotte, L.; Neirynck, S.; Obermeier, F.; Falk, W.; Fiers, W.; Remaut, E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000, 289, 1352-1355. (Pubitemid 30656052)
11. Jubeh, T. T.; Nadler-Milbauer, M.; Barenholz, Y.; Rubinstein, A. Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SOD. J. Drug Targeting 2006, 14, 155-163. (Pubitemid 43878824)
12. Jubeh, T. T.; Barenholz, Y.; Rubinstein, A. Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes. Pharm. Res. 2004, 21, 447-453. (Pubitemid 38338980)
13. Nugent, S. G.; Kumar, D.; Rampton, D. S.; Evans, D. F. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut 2001, 48, 571-577
14. Fallingborg, J. Intraluminal pH of the human gastrointestinal tract. Dan. Med. Bull. 1999, 46, 183-196
15. Fallingborg, J.; Christensen, L. A.; Jacobsen, B. A.; Rasmussen, S. N. Very low intraluminal colonic pH in patients with active ulcerative colitis. Dig. Dis. Sci. 1993, 38, 1989-1993 (Pubitemid 23336560)
16. Winterkamp, S.; Raithel, M.; Hahn, E. G. Secretion and tissue content of eosinophil cationic protein in Crohn's disease. J. Clin. Gastroenterol. 2000, 30, 170-175.
17. Lampinen, M.; Ronnblom, A.; Amin, K.; Kristjansson, G.; Rorsman, F.; Sangfelt, P.; Safsten, B.; Wagner, M.; Wanders, A.; Winqvist, O.; Carlson, M. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut 2005, 54, 1714-1720 (Pubitemid 41697669)
18. Monajemi, H.; Meenan, J.; Lamping, R.; Obradov, D. O.; Radema, S. A.; Trown, P. W.; Tytgat, G. N.; Van Deventer, S. J. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. Gastroenterology 1996, 110, 733-739 (Pubitemid 26071840)
19. Bevins, C. L. Paneth cells, defensins, and IBD. J. Pediatr. Gastroenterol. Nutr. 2008, 46, E14-5.
20. Garbuzenko, O.; Barenholz, Y.; Priev, A. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Chem. Phys. Lipids 2005, 135, 117-129 (Pubitemid 40744733)
21. Wallace, J. L.; Le, T.; Carter, L.; Appleyard, C. B.; Beck, P. L. Heptan-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. J. Pharmacol. Toxicol. Methods 1995, 33, 237-239.
22. Blau, S.; Kohen, R.; Bass, P.; Rubinstein, A. Relation between colonic inflammation severity and total low molecular weight antioxidant profiles in experimental colitis. Dig. Dis. Sci. 2000, 45, 1180-1187. (Pubitemid 30409464)
23. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
24. Shmeeda, H.; Even-Chen, S.; Honen, R.; Cohen, R.; Weintraub, C.; Barenholz, Y. Enzymatic assays for quality control and pharmacokinetics of liposome formulations: comparison with nonenzymatic conventional methodologies. Methods Enzymol. 2003, 367, 272-292. (Pubitemid 37337839)
25. Bartthe, L.; Woodley, J. F.; Kenworthy, S.; Houin, G. An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. Eur. J. Drug Metab. Pharmacokinet. 1998, 23, 313-323. (Pubitemid 28401125)
26. Frieri, G.; Giacomelli, R.; Pimpo, M.; Palumbo, G.; Passacantando, A.; Pantaleoni, G.; Caprilli, R. Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis. Gut 2000, 47, 410-414 (Pubitemid 30670837)
27. Quigley, E. M. The efficacy of probiotics in IBS. J. Clin. Gastroenterol. 2008, 42, S85-90.
28. Nakase, H.; Okazaki, K.; Tabata, Y.; Uose, S.; Ohana, M.; Uchida, K.; Matsushima, Y.; Kawanami, C.; Oshima, C.; Ikada, Y.; Chiba, T. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy. J. Pharmacol. Exp. Ther. 2000, 292, 15-21. (Pubitemid 30026351)
29. Nakase, H.; Okazaki, K.; Tabata, Y.; Chiba, T. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease. J. Gastroenterol. 2003, 38, 59-62. (Pubitemid 36442889)
30. Lamprecht, A.; Yamamoto, H.; Takeuchi, H.; Kawashima, Y. Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats. J. Pharmacol. Exp. Ther. 2005, 315, 196-202. (Pubitemid 41380512)
31. Lamprecht, A.; Ubrich, N.; Yamamoto, H.; Schafer, U.; Takeuchi, H.; Maincent, P.; Kawashima, Y.; Lehr, C. M. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 2001, 299, 775-781.
32. Ekstrom, G. M.; Andersson, S. E. Plasma exudation, hyperaemia, and epithelial permeability in rats with oxazolone-induced colitis: modulatory effects of budesonide. Scand. J. Gastroenterol. 2000, 35, 190-197
33. Mankertz, J.; Schulzke, J. D. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr. Opin. Gastroenterol. 2007, 23, 379-383 (Pubitemid 46878948)
34. Sharp, P.; Srai, S. K. Molecular mechanisms involved in intestinal iron absorption. World J. Gastroenterol. 2007, 13, 4716-4724 (Pubitemid 47455562)
35. Kolachala, V. L.; Sesikeran, B.; Nair, K. M. Evidence for a sequential transfer of iron amongst ferritin, transferrin and transferrin receptor during duodenal absorption of iron in rat and human. World J. Gastroenterol. 2007, 13, 1042-1052
36. Bergers, J. J.; Vingerhoeds, M. H.; van Bloois, L.; Herron, J. N.; Janssen, L. H.; Fischer, M. J.; Crommelin, D. J. The role of protein charge in protein-lipid interactions. pH-dependent changes of the electrophoretic mobility of liposomes through adsorption of watersoluble, globular proteins. Biochemistry 1993, 32, 4641-4649
37. Morales, C.; Sylvester, S. R.; Griswold, M. D. Transport of iron and transferrin synthesis by the seminiferous epithelium of the rat in vivo. Biol. Reprod. 1987, 37, 995-1005.
38. Nadler-Milbauer, M.; Azab, A. K.; Kleinstern, J.; Barenholz, Y.; Rubinstein, A. In vitro and in vivo analysis of pulsatile biodegradation of mucoadhesive hydrogels. J. Drug Delivery Sci. Technol., in press.